Covid-19, because it can rarely become serious in children

Covid-19, because it can rarely become serious in children

Experts explain what can happen and why children rarely develop a particularly severe form of Covid-19

It is a very rare reality. But there are cases in which Covid-19 can become particularly worrying even in children, who more often have almost no symptoms related to Sars-CoV-2 virus infection or in any case have ailments similar to those of a cold or a mild flu. The experts present at the Congress of the Italian Society of Pediatric Allergy and Immunology (SIAIP) explain what happens in this situation.

The role of genetics in the response

To explain what can happen in a very small number of children who contract the virus is Luigi Notarangelo, Director of the American Laboratory of Clinical Immunology and Microbiology of the NIH (National Institute of Health), who has investigated precisely this aspect.

"Our starting hypothesis was that some of the subjects who developed a particularly severe form of Covid-19 had a basic genetic defect in the ability of the immune system to cope with the virus and that, on the contrary, subjects who, while presenting comorbidities" – explains the expert.

"These subjects, despite being elderly, when exposed to the virus do not develop disease, have a genetic constitution capable of determining resistance to viral infection. In collaboration with various Italian centers we have studied the genome of these subjects, focusing in particular on genes involved in defense mechanisms against viruses.

We already knew that alterations in some of these genes are responsible for fatal forms of influenza. In fact, we observed the presence of mutations in these 13 genes in 3.5% of patients with a critical form of Covid-19. These are genes that are important for producing first type interferons which in the initial phase of a viral infection, before the specific immunity responses with the production of antibodies and T lymphocytes are triggered, are produced by the immune system and by the cells of the respiratory tract infected by the virus with the aim of reducing viral replication as much as possible ".

If for genetic reasons an individual is unable to produce first type interferon, the virus remains free to replicate and thus manages to spread much more in the body. But the researchers also made another observation. "10% of subjects with critical Covid-19 – concludes the expert – without genetic defects had autoantibodies against first type interferons that blocked their activity, leaving the virus free to replicate".

These are observations destined to affect therapy with the use, for example, at a very early stage of the disease, of interferons in patients unable to produce them or with interventions that allow the elimination of antibodies against interferons in patients presenting them.

Vaccines, but not only

Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) in Bethesda. Virtually present at the congress, he remembers that vaccines are not the only way out of the pandemic.

“Having recently entered the second year of this historic Covid-19 pandemic, we are all understandably exhausted, eager to end the suffering, tragic deaths and constraints the pandemic has placed on our lives. Extraordinarily, we have created in record time – explains Fauci – several vaccines against Covid-19 that have shown great effectiveness by offering us the hope of having the tools in hand to defeat Sars VOC 2.

Although vaccines are essential to achieve this goal, obviously we cannot consider them our only way out of the pandemic. It is necessary to act on two fronts: vaccinate as many people as possible in the shortest possible time while continuing to follow public health prevention measures. We can put an end to this pandemic, but when we do it depends on the commitment of each of us to be part of the solution ".

"The scientific objective of our society is that of a transversal vision of allergology and immunology – reports the SIAIP president Gian Luigi Marseglia, Director of the Pediatric Clinic of the University of Pavia, Fondazione IRCCS Policlinico San Matteo – It is not focused only on purely allergological or purely immunological diseases, but to the evaluation of all pathologies in which allergology and immunology represent the common denominator of the child's diseases. This is why we also deal with rheumatology, the immunological aspects of gastrointestinal diseases, the allergological and immunological aspects of diseases of the central nervous system and so on ”.

Read also

  • Allergy in the time of Covid-19, what to do with children
  • Covid-19 vaccine and allergies, what and how to do
  • Covid-19, so genes and cold viruses could limit the infection
  • Covid-19 and English variant, what happens in children
  • Covid-19, when a vaccine for children will arrive

Tag: Children Coronavirus

Category: Health
Previous Post
Name That Tune: Anna Tatangelo sets the trend in body. Orietta Berti "betrayed"
Next Post
It was Maria di Un Medico in Famiglia, today she changed her life (and work)

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed